$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
斯沃(利奈唑胺)多少钱一盒?哪里有卖?
2025-10-19 11:44:20
Check Details
2021年利奈唑胺片一盒多少钱?进医保了吗?
2025-10-19 11:44:20
Check Details
【医保资讯】2021年贝达喹啉在国内医保能给予报销吗?
2025-10-19 11:44:20
Check Details
【用药早知道】斯沃(利奈唑胺)是顶级的抗生素吗?
2025-10-19 11:44:20
Check Details
【关注度高】贝达喹啉一盒24粒的多少钱?
2025-10-19 11:44:20
Check Details
【带你知道】贝达喹啉是由哪个公司生产的?
2025-10-19 11:44:20
Check Details
贝达喹啉获FDA加速批准用于其他药物治疗无效的耐多药结核患者
2025-10-19 11:44:20
Check Details
【热点】贝达喹啉可有效降低耐药结核病风险
2025-10-19 11:44:20
Check Details
【患者关心】贝达喹啉纳入医保后的价格是多少?
2025-10-19 11:44:20
Check Details
贝达喹啉多少钱一盒?哪里买的到?看完就知道了
2025-10-19 11:44:20
Check Details
抗结核新药贝达喹啉多少钱一盒?贝达喹啉原研药价格?
2025-10-19 11:44:20
Check Details
肺部感染吃莫西沙星需要几天
2025-10-19 11:44:20
Check Details
1
2
...
3649
3650
3651
3652
3653
3654
3655
...
10230
10231
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Selpercatinib: Dosing and Administration Essentials of an Oral RET Inhibitor
2
Enasidenib: A Targeted IDH2 Inhibitor for Acute Myeloid Leukemia
3
Alpelisib: From Breast Cancer to PIK3CA-Related Overgrowth Spectrum
4
Ponatinib in Chronic Myeloid Leukemia: 5-Year Results from the OPTIC Trial
5
Erdafitinib Oral Tablets: Strengths, Packaging, and Dose Adjustment
6
Capmatinib (Tabrecta): Oral Targeted Therapy for MET Exon 14 Skipping-Mutated NSCLC
7
Amivantamab Plus Lazertinib: A Chemotherapy-Free First-Line Option in EGFR-Mutated NSCLC
8
Midostaurin (Rydapt): Dosing Essentials in FLT3-Mutated AML and Systemic Mastocytosis
9
Lapatinib: An Oral Dual EGFR/HER2 TKI in HER2-Positive Breast Cancer
10
Filgotinib (Jyseleca) Overseas Guide: JAK1 Inhibitor for Rheumatoid Arthritis and Ulcerative Colitis
11
FDA Approves LISRAYA (brepocitinib): First Oral Targeted Therapy for Adults with Dermatomyositis
12
Elagolix for Endometriosis Pain: Indications and Usage Guidelines